The role of CYP-sEH derived lipid mediators in regulating mitochondrial biology and cellular senescence: implications for the aging heart

A Yousef, L Fang, M Heidari, J Kranrod… - Frontiers in …, 2024 - frontiersin.org
Cellular senescence is a condition characterized by stable, irreversible cell cycle arrest
linked to the aging process. The accumulation of senescent cells in the cardiac muscle can …

Sex-Specific Response of the Brain Free Oxylipin Profile to Soluble Epoxide Hydrolase Inhibition

JE Norman, S Nuthikattu, D Milenkovic, JC Rutledge… - Nutrients, 2023 - mdpi.com
Oxylipins are the oxidation products of polyunsaturated fatty acids and have been implicated
in neurodegenerative disorders, including dementia. Soluble epoxide hydrolase (sEH) …

Overcoming the Challenges of Multi‐Target‐Directed Ligands for Alzheimer's Disease: Tips and Examples

E Uliassi, AM Pasieka, E Diamanti… - … : Strategies for Multi …, 2025 - Wiley Online Library
The concept of multi‐target‐directed ligands has been quite successful within the drug
discovery community, due to its potential to better address the multifactorial nature of …

The effect of soluble epoxide hydrolase inhibition on the mononuclear phagocyte system during inflammation

OV Bracken - 2023 - discovery.ucl.ac.uk
Evidence suggests a role for Cytochrome P450 metabolites, namely the epoxy-oxylipins, in
facilitating the inflammatory response. The soluble epoxide hydrolase (sEH) enzyme …

[HTML][HTML] Ureas derived from camphor and fenchone reveal enantiomeric preference of human soluble epoxide hydrolase

V Burmistrov, C Morisseau, D Pitushkin, RR Fayzullin… - Results in chemistry, 2022 - Elsevier
The soluble epoxide hydrolase (sEH) is a potential target to treat cardiovascular, renal and
neuronal diseases. A series of sEH inhibitors containing naturally occurring lipophilic groups …

Ureas derived from camphor and fenchone reveal enantiomeric preference of human soluble epoxide hydrolase

V Burmistrov, C Morisseau, D Pitushkin, RR Fayzullin… - 2022 - escholarship.org
The soluble epoxide hydrolase (sEH) is a potential target to treat cardiovascular, renal and
neuronal diseases. A series of sEH inhibitors containing naturally occurring lipophilic groups …